Last reviewed · How we verify
Intramuscular injection of TAK-850 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Intramuscular injection of TAK-850 (Intramuscular injection of TAK-850) — Takeda.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intramuscular injection of TAK-850 TARGET | Intramuscular injection of TAK-850 | Takeda | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intramuscular injection of TAK-850 CI watch — RSS
- Intramuscular injection of TAK-850 CI watch — Atom
- Intramuscular injection of TAK-850 CI watch — JSON
- Intramuscular injection of TAK-850 alone — RSS
Cite this brief
Drug Landscape (2026). Intramuscular injection of TAK-850 — Competitive Intelligence Brief. https://druglandscape.com/ci/intramuscular-injection-of-tak-850. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab